Home › Opioid Overdose › District of Columbia › Washington
Opioid Overdose clinical trials in Washington, DC
4 studies for Opioid Overdose are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
RecruitingHealthy volunteers welcome
- HIPS, Washington D.C.
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Recruiting
- HIPS Clinic, Washington D.C.
- University of Maryland, College Park, College Park · 8 mi away
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Recruiting
- George Washington University, Washington D.C.
Focused Ultrasound for the Complex Patient
RecruitingHealthy volunteers welcome
- Washington DC Veterans Affairs Medical Center, Washington D.C.
About Opioid Overdose
Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.
More about Opioid Overdose on MedlinePlus
Opioid Overdose trials in other cities
- Baltimore, MD18 studies
- New Haven, CT17 studies
- Philadelphia, PA15 studies
- New York City, NY12 studies
- Boston, MA12 studies
- Birmingham, AL7 studies
- Salt Lake City, UT7 studies
- Pittsburgh, PA7 studies
- Charleston, SC6 studies
- San Francisco, CA6 studies
- Providence, RI6 studies
- Chicago, IL5 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.